off-label use of glp-1 agonists for obesity in 2016 Weight Reduction with and Paths Discontinuation While Maintaining Weight Loss Prevalence of use and interest

Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, et al

The prevalence of complications associated with obesity, including dyslipidaemia, hypertension, fatty liver disease and psychosocial complications are becoming increasingly prevalent within the paediatric populations

Incretin-Based Therapy and Type 2 Diabetes

For researchers managing metabolic health beyond the number on the scale, this benefit has no equivalent in tirzepatide protocols

From celebrity endorsements to social media buzz, these medications have sparked excitement, debate, and many questions

GLP-1 receptors arent just found in the pancreas and brain